Xiangyu Medical Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	760.37	722.46	743.18	663.78	726.31	829.62
Trading Asset Securities	71.3	52	-	162.19	636.47	648.14
Cash & Short-Term Investments	831.66	774.46	743.18	825.98	1,363	1,478
Cash Growth	-4.54%	4.21%	-10.02%	-39.39%	-7.78%	203.29%
Accounts Receivable	86.93	60.82	67.7	57.99	34.35	43.03
Other Receivables	12.19	9.93	15.24	7.42	5	4.37
Receivables	99.12	70.75	82.95	65.41	39.35	47.4
Inventory	323.61	304.2	238.21	241.37	222.82	159.4
Prepaid Expenses	-	-	-	-	-	1.78
Other Current Assets	342.73	336.9	77.38	61.6	43.42	30.18
Total Current Assets	1,597	1,486	1,142	1,194	1,668	1,717
Property, Plant & Equipment	1,415	1,397	1,216	834.36	407.96	170.9
Long-Term Investments	33.07	24.81	266.03	258.52	17.09	16.71
Other Intangible Assets	211.66	214.37	216.89	207.7	204.25	208.78
Long-Term Accounts Receivable	-	-	33.53	47.79	43.03	50.2
Long-Term Deferred Tax Assets	15.05	13.92	9.55	11.22	14.7	11.4
Long-Term Deferred Charges	28.79	26.18	16.57	5.72	1.51	1.47
Other Long-Term Assets	68.59	105.54	27.14	32.47	11.15	6.57
Total Assets	3,369	3,268	2,928	2,592	2,368	2,183
Accounts Payable	108.83	122.65	135.62	109.69	103.87	27.71
Accrued Expenses	30.67	30.54	60.56	62.61	45.46	33.49
Short-Term Debt	518.94	482.52	354.1	27.02	17.15	-
Current Portion of Long-Term Debt	3.95	4.13	-	-	-	-
Current Portion of Leases	-	-	1.12	-	-	-
Current Income Taxes Payable	8.9	7.34	1.45	5.06	2.01	8.71
Current Unearned Revenue	162.74	181.48	127.97	107.56	135.69	64.23
Other Current Liabilities	118.13	122.19	53.89	60.21	47.62	47.27
Total Current Liabilities	952.17	950.84	734.71	372.14	351.8	181.42
Long-Term Debt	145.38	80.52	-	-	-	-
Long-Term Leases	6.93	7.02	11.14	8.44	-	-
Long-Term Unearned Revenue	150.01	149.03	127.25	104.11	65.1	53.72
Long-Term Deferred Tax Liabilities	-	-	-	-	11.31	1.83
Total Liabilities	1,254	1,187	873.1	484.69	428.22	236.97
Common Stock	160	160	160	160	160	160
Additional Paid-In Capital	1,323	1,314	1,299	1,294	1,294	1,294
Retained Earnings	822.54	797.22	756.04	735.7	546.36	480.83
Treasury Stock	-201.83	-201.83	-176.5	-98.93	-73.27	-
Total Common Equity	2,104	2,070	2,039	2,091	1,928	1,935
Minority Interest	10.33	10.75	16.1	16.53	12.27	10.53
Shareholders' Equity	2,114	2,080	2,055	2,107	1,940	1,946
Total Liabilities & Equity	3,369	3,268	2,928	2,592	2,368	2,183
Total Debt	675.21	574.2	366.35	35.46	17.15	-
Net Cash (Debt)	156.46	200.26	376.83	790.52	1,346	1,478
Net Cash Growth	-44.00%	-46.86%	-52.33%	-41.25%	-8.94%	237.97%
Net Cash Per Share	1.01	1.31	2.42	5.01	8.47	9.88
Filing Date Shares Outstanding	158.26	158.01	154.19	157.11	157.73	160
Total Common Shares Outstanding	158.26	158.01	155.1	157.11	157.73	160
Working Capital	644.96	535.46	407	822.21	1,317	1,535
Book Value Per Share	13.30	13.10	13.14	13.31	12.22	12.09
Tangible Book Value	1,893	1,855	1,822	1,883	1,723	1,726
Tangible Book Value Per Share	11.96	11.74	11.75	11.99	10.93	10.79
Buildings	-	-	884.79	326.28	96.84	96.84
Machinery	-	-	173.84	146.98	61.96	52.32
Construction In Progress	-	-	252.27	428.83	314.09	77.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.